Deletion of Inducible Nitric Oxide Synthase Provides Cardioprotection in Mice With 2-Kidney, 1-Clip Hypertension

No abstract is available for this paper.

• Publication year

  2009

• Venue

  HYPERTENSION

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.108.121822PMID 19001185PMCID PMC2636504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.

  2008cited by this paper
• Oxidative remodeling in pressure overload induced chronic heart failure

  2007cited by this paper
• Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-&kgr;B-Dependent Pathway

  2007cited by this paper
• Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure

  2007cited by this paper
• [Angiotensin II up-regulates expression of inducible nitric oxide synthase in human umbilical endothelial cells: roles of AT1 and AT2].

  2006cited by this paper
• Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.

  2006cited by this paper
• SERCA overexpression reduces hydroxyl radical injury in murine myocardium.

  2006cited by this paper
• The ubiquitous role of nitric oxide in cardioprotection.

  2006cited by this paper
• The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines.

  2005cited by this paper
• Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.

  2005cited by this paper
• Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.

  2005cited by this paper
• Inducible Nitric Oxide Synthase Inhibitors Reduce Urinary Markers of Systemic Oxidant Stress in Murine Proliferative Lupus Nephritis

  2005cited by this paper
• Lack of Inducible NO Synthase Reduces Oxidative Stress and Enhances Cardiac Response to Isoproterenol in Mice With Deoxycorticosterone Acetate–Salt Hypertension

  2005cited by this paper
• Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine

  2004cited by this paper
• Cardiac Angiotensin II Participates in Coronary Microvessel Inflammation of Unstable Angina and Strengthens the Immunomediated Component

  2004cited by this paper
• Laminar shear stress up-regulates inducible nitric oxide synthase in the endothelium.

  2004cited by this paper
• Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

  2004cited by this paper
• Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats.

  2003cited by this paper
• Inhibition of inducible nitric oxide synthase during high dietary salt intake.

  2002cited by this paper
• BMC Cardiovascular Disorders BioMed Central BMC 2002, Cardiovascular Disorders

  2002cited by this paper
• Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms

  2002cited by this paper
• Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death.

  2002cited by this paper
• Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats

  2002cited by this paper
• Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and &bgr;-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure

  2002cited by this paper
• Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.

  2002cited by this paper
• Disruption of Inducible Nitric Oxide Synthase Improves &bgr;-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy

  2002cited by this paper
• Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and β-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure

  2002cited by this paper
• Disruption of inducible nitric oxide synthase improves β-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy

  2002cited by this paper
• Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.

  2001cited by this paper
• Increased Inducible Nitric Oxide Synthase Expression Contributes to Myocardial Dysfunction and Higher Mortality After Myocardial Infarction in Mice

  2001cited by this paper
• Mice Lacking Inducible Nitric Oxide Synthase Have Improved Left Ventricular Contractile Function and Reduced Apoptotic Cell Death Late After Myocardial Infarction

  2001cited by this paper
• Paracrine and autocrine effects of nitric oxide on myocardial function.

  2000cited by this paper
• Effects of inducible nitric oxide synthase inhibition on cerebral edema in severe hypertension.

  2000cited by this paper
• INCREASED INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION CONTRIBUTES TO MYOCARDIAL DYSFUNCTION AND HIGHER MORTALITY POST MYOCARDIAL INFARCTION IN MICE: P1.213

  2000cited by this paper
• Congenital Deficiency of Nitric Oxide Synthase 2 Protects Against Endotoxin-Induced Myocardial Dysfunction in Mice

  2000cited by this paper
• Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase

  2000cited by this paper
• Shear stress induces iNOS expression in cultured smooth muscle cells: role of oxidative stress.

  2000cited by this paper
• Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.

  1999cited by this paper
• Echocardiographic assessment of cardiac function in conscious and anesthetized mice.

  1999cited by this paper
• Nitric oxide synthase in cardiac sarcoplasmic reticulum.

  1999cited by this paper
• Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.

  1999cited by this paper
• Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors.

  1998cited by this paper
• Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site.

  1997cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1997cited by this paper
• Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors.

  1997cited by this paper
• Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide.

  1997cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.

  1997cited by this paper
• Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages.

  1997cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1996cited by this paper
• Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.

  1996cited by this paper
• Mechanisms of Oxidant Stress-Induced Acute Tissue Injury

  1995cited by this paper
• Nitric oxide and its role in the cardiovascular system.

  1995cited by this paper

• Morphometric and Molecular Interplay in Hypertension-Induced Cardiac Remodeling with an Emphasis on the Potential Therapeutic Implications

  2025cites this paper
• Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease

  2023cites this paper
• Some Aspects of Role of Nitric Oxide in the Mechanisms of Hypertension (Experimental Study)

  2020cites this paper
• Chronic L-Name-Treatment Produces Hypertension by Different Mechanisms in Peripheral Tissues and Brain: Role of Central eNOS

  2020cites this paper
• Role of Kinins in Hypertension and Heart Failure

  2020cites this paper
• Chronic infusion of berberine into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation via the ROS/Erk1/2/iNOS pathway.

  2019cites this paper
• Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats

  2018cites this paper
• S-Nitrosylation Suppresses Stromal Interaction Molecule-1 Activation and Ameliorates Cardiomyocyte Hypertrophy

  2017cites this paper
• Vascular Remodelling Relates to an Elevated Oscillatory Shear Index and Relative Residence Time in Spontaneously Hypertensive Rats

  2017cites this paper
• Post-infarct sleep disruption and its relation to cardiac remodeling in a rat model of myocardial infarction

  2017cites this paper
• Signalling Microdomains: The Beta-3 Adrenergic Receptor/NOS Signalosome

  2017cites this paper
• Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.

  2016cites this paper
• Inducible nitric oxide synthase as a possible target in hypertension.

  2014cites this paper
• Investigational drugs targeting cardiac fibrosis

  2014cites this paper
• Pathophysiology of Hypertension in the Absence of Nitric Oxide/Cyclic GMP Signaling

  2013cites this paper
• Evolution of cardiac and renal impairment detected by high-field cardiovascular magnetic resonance in mice with renal artery stenosis

  2013cites this paper
• Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling.

  2012cites this paper
• Simvastatin Ameliorates Angiotensin II-Induced Endothelial Dysfunction Through Restoration of Rho-BH4-eNOS-NO Pathway

  2012cites this paper
• Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced oxidative stress and vascular dysfunction in mice.

  2012cites this paper
• Endothelin-1 overexpression restores diastolic function in eNOS knockout mice

  2011cites this paper
• MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-кB activation via inhibition of IкB kinase activation.

  2011cites this paper
• Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension

  2011cites this paper
• Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.

  2010cites this paper
• Nitric oxide pathway in hypertrophied heart: new therapeutic uses of nitric oxide donors

  2010cites this paper
• Current World Literature

  2010cites this paper
• Role of Proinflammatory Cytokines and Redox Homeostasis in Exercise-Induced Delayed Progression of Hypertension in Spontaneously Hypertensive Rats

  2009cites this paper
• Exercise and Proinflammatory Cytokines Role of Proinflammatory Cytokines and Redox Homeostasis in Exercise-Induced Delayed Progression of Hypertension in Spontaneously Hypertensive Rats

  2009cites this paper